CBOE Holdings, Inc (NASDAQ:CBOE) shares dropped 4.13% and closed at $48.74. The company on August 2 reported second quarter 2013 net income allocated to common stockholders of $45.5 million, or $0.52 per diluted share, compared with $37.9 million, or $0.44 per diluted share in the second quarter of 2012. Adjusted net income allocated to common stockholders […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares jumped 2.72% to $4.15. RIGL and AstraZeneca AB (AZ) on June 4 announced the topline results from OSKIRA-2 and OSKIRA-3, the remaining pivotal Phase 3 clinical trials investigating fostamatinib, the first oral spleen tyrosine kinase (SYK) inhibitor in development for rheumatoid arthritis (RA). MedAssets, Inc. (NASDAQ:MDAS) shares gained 2.72% to $23.40. The […]